Team finds gene therapy a promising tool for cardiac regeneration

After a heart attack, there is often permanent damage to a portion of the heart. This happens, in part, because cardiac muscle cells are terminally differentiated and cannot proliferate after blood flow is blocked off to the heart. This partial healing can be attributed to heart disease being one of the leading causes of death. What if the cells could be stimulated to divide and the heart could be induced to repair itself? This was the question posed by George Washington University (GW) researcher Scott Shapiro, M.D., Ph.D., and his co-authors, who found that cardiac regeneration may be a possibility with gene therapy.

The research, published yesterday in Science Translational Medicine, found that gene therapy can elicit a regenerative response in pig hearts. Shapiro and his research team first looked to small animals such as the zebrafish, which are able to regenerate heart tissue after a heart attack. This animal has a key protein at play, Cyclin A2 (Ccna2).

"After seeing the effects of CCna2 in small animals, we began looking at the effects of the gene in larger animals, such as pigs," said Shapiro, assistant professor of medicine at the GW School of Medicine and Health Sciences. "We delivered Ccna2 directly into the heart and found that pigs not only had improved cardiac function, but also found evidence of cellular regeneration."

Ccna2 is a prenatal gene normally turned off in humans after birth. Shapiro believes using as a tool for cardiac regeneration, optimized for humans, could lead to a viable treatment option for patients who suffer from myocardial infarction, or .

More information: The study, titled "Cyclin A2 Induces Cardiac Regeneration After Myocardial Infarction Through Cytokinesis of Adult Cardiomyocytes," is available at stm.sciencemag.org/content/6/224/224ra27.short

add to favorites email to friend print save as pdf

Related Stories

Breakthrough in adult heart repair

Nov 19, 2013

Researchers from the Baylor College of Medicine and the Texas Heart Institute have discovered a new way to dramatically improve heart repair. The future goal is to use this knowledge to combat human cardiovascular disease ...

Recommended for you

A novel therapy for sepsis?

8 hours ago

A University of Tokyo research group has discovered that pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering ...

Cellular protein may be key to longevity

Sep 15, 2014

Researchers have found that levels of a regulatory protein called ATF4, and the corresponding levels of the molecules whose expression it controls, are elevated in the livers of mice exposed to multiple interventions ...

Gut bacteria tire out T cells

Sep 15, 2014

Leaky intestines may cripple bacteria-fighting immune cells in patients with a rare hereditary disease, according to a study by researchers in Lausanne, Switzerland. The study, published in The Journal of Experimental Me ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

soniabrito44
not rated yet Feb 20, 2014

Research Chemicals

We sell and supply high quality

and purity research chemicals

in both large and small

quantities worldwide.
Our shipping and delivery cost

is 100% safe and convinient.
We are ready to sell minimum

quantities and large deliveries

to the world of our product.
Below is a list of currently

available products we have in

stock.
pain killers . oxy adderal

etc..
Nopaine
Mephedrone (4-MMC)
Methylone (bk-MDMA)
MDAI
Ketamine hcl crystal powder
Dimethocaine (Larocaine/DMC)
Bulytone (bk-MBDB)
MDPV
JWH-018 / JWH-250,JWH-018,JWH-

073,JWH-200
JWH-250
2C-B
2C-B-FLY 2C-Bromo-Fly
2C-C
2C-D
2C-E
2C-I
2C-T-2
2C-T-4
2C-T-7
2C-T-2
5-Meo-DMT
4-Aco-DMT
Naphyrone

We have some other chemicals we

supply upon request.
You can therefore make your

order by contacting us

soniabrito44@gmail.com